Pharmaceutical stocks remain attractive in 2022 on strong medicine demand

Pharmaceutical stocks remain attractive in 2022 on strong medicine demand

As the COVID-19 pandemic continues to spread nationwide and is gradually being considered an endemic disease that could be treated at home, demand for drugs has increased sharply.
Pharmaceutical enterprises enjoy good earnings in Q1

Pharmaceutical enterprises enjoy good earnings in Q1

Increasing demand for medicine amid the COVID-19 pandemic has helped most pharmaceutical enterprises report positive business results in the first quarter of this year.
Pharmaceutical stocks benefit from disease spread

Pharmaceutical stocks benefit from disease spread

Pharmaceutical stocks are experiencing an upsurge as fears of coronavirus have boosted demand for healthcare products and services, lifting demand for shares.